TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation
Clinical trial NCT07038928 · RECRUITING
Trial details
- NCT number
- NCT07038928
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-06-30
- Primary completion
- 2026-12-31
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.